应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RDY 如瑞迪博士
交易中 07-29 10:49:57 EDT
14.76
+0.05
+0.31%
最高
14.81
最低
14.72
成交量
29.89万
今开
14.75
昨收
14.71
日振幅
0.61%
总市值
122.82亿
流通市值
87.89亿
总股本
8.32亿
成交额
441.32万
换手率
0.05%
流通股本
5.96亿
市净率
2.90
ROE
17.71%
每股收益
0.79
52周最高
16.89
52周最低
12.26
市盈率
18.60
股息
0.10
股息收益率
0.01
ROA
9.71%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
专利即将解禁!如瑞迪博士(RDY.US)司美格鲁肽仿制药将登陆87国市场
智通财经 · 07-24
专利即将解禁!如瑞迪博士(RDY.US)司美格鲁肽仿制药将登陆87国市场
如瑞迪博士盘中异动 大幅上涨5.02%报15.49美元
市场透视 · 06-05
如瑞迪博士盘中异动 大幅上涨5.02%报15.49美元
汇丰:上调Dr Reddy's Laboratories评级,由持有调整至买入评级, 目标价由14.44美元调整至16.90美元。
金融界 · 06-05
汇丰:上调Dr Reddy's Laboratories评级,由持有调整至买入评级, 目标价由14.44美元调整至16.90美元。
如瑞迪博士2025财年实现净利润6.69亿美元,同比减少0.59%
市场透视 · 05-18
如瑞迪博士2025财年实现净利润6.69亿美元,同比减少0.59%
异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压
异动解读 · 01-23
异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压
如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元
市场透视 · 01-23
如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元
Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元
财报速递 · 01-23
Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元
如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元
市场透视 · 2024-12-19
如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元
如瑞迪博士2024财年第三财季实现净利润1.50亿美元,同比减少16.20%
市场透视 · 2024-11-10
如瑞迪博士2024财年第三财季实现净利润1.50亿美元,同比减少16.20%
如瑞迪博士盘中异动 大幅拉升5.03%
市场透视 · 2024-11-06
如瑞迪博士盘中异动 大幅拉升5.03%
加载更多
公司概况
公司名称:
如瑞迪博士
所属市场:
NYSE
上市日期:
2001-04-11
主营业务:
如瑞迪博士实验室有限公司成立于1984年2月24日,其一体化的全球制药公司通过其三个核心业务部门:全球仿制药分部,医药服务与活性成分部门(PSAI)和专有产品分部,致力于提供价格优惠的新型药物。其全球品牌和无品牌仿制药部分包括处方药和非处方药(OTC)药品经营。公司的医药服务与活性成分部门(PSAI)成由药物成分(API)业务和药学服务定制组成。公司专利产品部分下设生物制药企业,新化学实体业务,分化配方业务及通过promius制药公司运营的皮肤科专业的业务重点企业。
发行价格:
--
{"stockData":{"symbol":"RDY","market":"US","secType":"STK","nameCN":"如瑞迪博士","latestPrice":14.755,"timestamp":1753800564169,"preClose":14.71,"halted":0,"volume":298917,"delay":0,"floatShares":595667231,"shares":832370850,"eps":0.793243,"marketStatus":"交易中","change":0.045,"latestTime":"07-29 10:49:53 EDT","open":14.75,"high":14.81,"low":14.72,"amount":4413163.359114,"amplitude":0.006118,"askPrice":14.76,"askSize":605,"bidPrice":14.75,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.793243,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753819200000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":986961600000,"exchange":"NYSE","adjPreClose":14.71,"dividendRate":0.006563,"preHourTrading":{"tag":"盘前","latestPrice":14.84,"preClose":14.71,"latestTime":"09:24 EDT","volume":4164,"amount":61788.521688,"timestamp":1753795466068},"postHourTrading":{"tag":"盘后","latestPrice":14.7,"preClose":14.7,"latestTime":"17:08 EDT","volume":22016,"amount":323635.33,"timestamp":1753736911386},"volumeRatio":0.943996,"impliedVol":0.2154,"impliedVolPercentile":0.584},"requestUrl":"/m/hq/s/RDY","defaultTab":"news","newsList":[{"id":"2553222152","title":"专利即将解禁!如瑞迪博士(RDY.US)司美格鲁肽仿制药将登陆87国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222152","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222152?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:54","pubTimestamp":1753322093,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据报道,如瑞迪博士 首席执行官透露,该公司计划自2026年起在87个国家推出诺和诺德减肥药Wegovy活性成分司美格鲁肽的仿制药版本。随着该药物全球专利陆续到期,公司已在多个市场启动注册申报程序。如瑞迪博士的仿制药将率先登陆加拿大、巴西和印度等市场。Israeli特别强调,公司还将在诺和诺德未取得专利保护的国家同步推进上市计划。Israeli指出该药物具有强劲的商业前景,预计司美格鲁肽仿制药可带来数亿美元的增量收入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"专利即将解禁!如瑞迪博士(RDY.US)司美格鲁肽仿制药将登陆87国市场","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RDY","BK4007","BK4596","BK4532","LU0348744763.USD","BK4557","BK4523"],"gpt_icon":0},{"id":"2541707529","title":"如瑞迪博士盘中异动 大幅上涨5.02%报15.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541707529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541707529?lang=zh_cn&edition=full","pubTime":"2025-06-05 21:42","pubTimestamp":1749130970,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时42分,如瑞迪博士股票出现波动,股价大幅上涨5.02%。截至发稿,该股报15.49美元/股,成交量13.5275万股,换手率0.02%,振幅2.24%。如瑞迪博士股票所在的制药行业中,整体跌幅为0.59%。瑞迪博士还拥有活性药物成分业务,生产超过150种原料药,并在超过75个国家销售。该信息摘要如下:汇丰:上调Dr Reddy's Laboratories评级,由持有调整至买入评级, 目标价由14.44美元调整至16.90美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605214250a6fbda1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605214250a6fbda1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4523","RDY","LU0348744763.USD","BK4007","BK4596","BK4532","BK4557"],"gpt_icon":0},{"id":"2541020751","title":"汇丰:上调Dr Reddy's Laboratories评级,由持有调整至买入评级, 目标价由14.44美元调整至16.90美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541020751","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541020751?lang=zh_cn&edition=full","pubTime":"2025-06-05 20:12","pubTimestamp":1749125561,"startTime":"0","endTime":"0","summary":"汇丰:上调Dr Reddy's Laboratories(RDY.US)评级,由持有调整至买入评级, 目标价由14.44美元调整至16.90美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605202609950ff86f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605202609950ff86f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDY","HSBC"],"gpt_icon":0},{"id":"2536594895","title":"如瑞迪博士2025财年实现净利润6.69亿美元,同比减少0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594895","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594895?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584022,"startTime":"0","endTime":"0","summary":"5月19日,如瑞迪博士公布财报,公告显示公司2025财年净利润为6.69亿美元,同比减少0.59%;其中营业收入为38.50亿美元,同比增加14.18%,每股基本收益为0.80美元。机构评级:截至2025年5月19日,当前有32家机构对如瑞迪博士目标价做出预测,其中目标均价为14.81美元,其中最低目标价为11.83美元,最高目标价为18.60美元。瑞迪博士还拥有活性药物成分业务,生产超过150种原料药,并在超过75个国家销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000047a6e3a6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000047a6e3a6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDY"],"gpt_icon":0},{"id":"1174309415","title":"异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压","url":"https://stock-news.laohu8.com/highlight/detail?id=1174309415","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174309415?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:12","pubTimestamp":1737645150,"startTime":"0","endTime":"0","summary":"如瑞迪博士(RDY.US)股价今日盘中出现大幅下跌,最高下挫逾5.1%。\n\n分析指出,这一走低行情或与公司近期财报利空有关。如瑞迪博士近期公布的2025财年第三季度财报显示,公司当季每股收益为0.20美元,与去年同期持平。而公司季度营收则为9.77亿美元,同比增长15.9%。从财报数据来看,公司业绩增长较为乏力,未有亮眼表现,这或令市场失望,减弱了投资者信心,从而引发股价下跌。\n\n不过,由于公司整体经营状况尚可,市场分析人士预计,股价下跌幅度或将受到一定限制。后续公司还需在投资者关系管理方面进一步加强,以稳定投资者信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RDY"],"gpt_icon":0},{"id":"2505012923","title":"如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505012923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505012923?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:04","pubTimestamp":1737644694,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时04分,如瑞迪博士股票出现异动,股价急速下挫5.10%。截至发稿,该股报14.32美元/股,成交量17.8924万股,换手率0.02%,振幅4.01%。最近的财报数据显示,该股实现营业收入9.57亿美元,净利润1.50亿美元,每股收益0.18美元,毛利5.44亿美元,市盈率18.17倍。机构评级方面,在所有39家参与评级的机构中,41%的券商给予买入建议,33%的券商给予持有建议,26%的券商给予卖出建议。如瑞迪博士股票所在的制药行业中,整体跌幅为0.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230455960e4b27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230455960e4b27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDY","BK4007","BK4532","LU0348744763.USD","BK4596","BK4557","BK4523"],"gpt_icon":0},{"id":"1171469608","title":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171469608","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171469608?lang=zh_cn&edition=full","pubTime":"2025-01-23 20:50","pubTimestamp":1737636634,"startTime":"0","endTime":"0","summary":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益为0.20美元,同比为0.19美元,销售额为9.77亿美元,而去年同期为8.43亿美元以上内容来自Benzinga Earnings专栏,原文如下:Dr Reddy's Laboratories Q3 2025 GAAP EPS $0.20 Versus $0.19 YoY, Sales $977.00M Compared To $843M YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元,同比0.19美元,销售额9.77亿美元,同比增长8.43亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDY"],"gpt_icon":0},{"id":"2492584179","title":"如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492584179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492584179?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:30","pubTimestamp":1734618633,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时30分,如瑞迪博士股票出现波动,股价急速拉升5.15%。截至发稿,该股报15.30美元/股,成交量7.1198万股,换手率0.01%,振幅0.07%。最近的财报数据显示,该股实现营业收入9.57亿美元,净利润1.50亿美元,每股收益0.18美元,毛利5.44亿美元,市盈率19.18倍。如瑞迪博士股票所在的制药行业中,整体涨幅为0.00%。如瑞迪博士公司简介:Dr. Reddy's Laboratories Ltd 总部位于印度,开发和制造销往世界各地的仿制药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223033ab849ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223033ab849ddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","RDY","BK4523","LU0348744763.USD","BK4532","BK4596","BK4007"],"gpt_icon":0},{"id":"2482267393","title":"如瑞迪博士2024财年第三财季实现净利润1.50亿美元,同比减少16.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482267393?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254428,"startTime":"0","endTime":"0","summary":"11月11日,如瑞迪博士公布财报,公告显示公司2024财年第三财季净利润为1.50亿美元,同比减少16.20%;其中营业收入为9.57亿美元,同比增加15.02%,每股基本收益为0.18美元。从资产负债表来看,如瑞迪博士总负债18.70亿美元,其中短期债务4.91亿美元,资产负债比为2.98,流动比率为1.92。机构评级:截至2024年11月11日,当前有37家机构对如瑞迪博士目标价做出预测,其中目标均价为16.22美元,其中最低目标价为12.70美元,最高目标价为19.64美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDY"],"gpt_icon":0},{"id":"2481998549","title":"如瑞迪博士盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481998549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481998549?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903458,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分,如瑞迪博士股票出现异动,股价大幅上涨5.03%。截至发稿,该股报15.35美元/股,成交量1.5724万股,换手率0.00%,振幅0.27%。机构评级方面,在所有37家参与评级的机构中,32%的券商给予买入建议,35%的券商给予持有建议,33%的券商给予卖出建议。如瑞迪博士股票所在的制药行业中,整体涨幅为0.00%。如瑞迪博士公司简介:Dr. Reddy's Laboratories Ltd 总部位于印度,开发和制造销往世界各地的仿制药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223106a21d29d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223106a21d29d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4596","RDY","LU0348744763.USD","BK4557","BK4523","BK4007","BK4532"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.drreddys.com","stockEarnings":[{"period":"1week","weight":0.0103},{"period":"1month","weight":-0.0246},{"period":"3month","weight":0.0545},{"period":"6month","weight":0.0873},{"period":"1year","weight":-0.0951},{"period":"ytd","weight":-0.069}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"如瑞迪博士实验室有限公司成立于1984年2月24日,其一体化的全球制药公司通过其三个核心业务部门:全球仿制药分部,医药服务与活性成分部门(PSAI)和专有产品分部,致力于提供价格优惠的新型药物。其全球品牌和无品牌仿制药部分包括处方药和非处方药(OTC)药品经营。公司的医药服务与活性成分部门(PSAI)成由药物成分(API)业务和药学服务定制组成。公司专利产品部分下设生物制药企业,新化学实体业务,分化配方业务及通过promius制药公司运营的皮肤科专业的业务重点企业。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.020327},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.017685},{"month":3,"riseRate":0.708333,"avgChangeRate":0.034592},{"month":4,"riseRate":0.625,"avgChangeRate":0.025232},{"month":5,"riseRate":0.48,"avgChangeRate":-0.002855},{"month":6,"riseRate":0.68,"avgChangeRate":0.048941},{"month":7,"riseRate":0.4,"avgChangeRate":0.008135},{"month":8,"riseRate":0.5,"avgChangeRate":-0.006898},{"month":9,"riseRate":0.625,"avgChangeRate":0.023194},{"month":10,"riseRate":0.583333,"avgChangeRate":0.014339},{"month":11,"riseRate":0.666667,"avgChangeRate":0.00792},{"month":12,"riseRate":0.541667,"avgChangeRate":0.036697}],"exchange":"NYSE","name":"如瑞迪博士","nameEN":"Dr Reddy's Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供如瑞迪博士(RDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"如瑞迪博士,RDY,如瑞迪博士股票,如瑞迪博士股票老虎,如瑞迪博士股票老虎国际,如瑞迪博士行情,如瑞迪博士股票行情,如瑞迪博士股价,如瑞迪博士股市,如瑞迪博士股票价格,如瑞迪博士股票交易,如瑞迪博士股票购买,如瑞迪博士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供如瑞迪博士(RDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}